Home LiteratureArticle Details
PMID: 1420849 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.

Biometrics ·Vol. 48 ·No. 3 ·1992-09-00 ·Pages 951-9

Odell PM, Anderson KM, D'Agostino RB

Abstract

The accelerated failure time regression model is most commonly used with right-censored survival data. This report studies the use of a Weibull-based accelerated failure time regression model when left- and interval-censored data are also observed. Two alternative methods of analysis are considered. First, the maximum likelihood estimates (MLEs) for the observed censoring pattern are computed. These are compared with estimates where midpoints are substituted for left- and interval-censored data (midpoint estimator, or MDE). Simulation studies indicate that for relatively large samples there are many instances when the MLE is superior to the MDE. For samples where the hazard rate is flat or nearly so, or where the percentage of interval-censored data is small, the MDE is adequate. An example using Framingham Heart Study data is discussed.

MeSH Terms
Age Factors Computer Simulation Coronary Disease/epidemiology,mortality Epidemiologic Methods Humans Massachusetts Mathematics Probability Proportional Hazards Models Regression Analysis Survival Analysis
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Odell P M
Bryant College, Smithfield, Rhode Island 02917.
Anderson K M
D'Agostino R B
Article Info
Journal
Biometrics
Abbr.
Biometrics
ISSN
0006-341X
Published
1992-09-00
Pages
951-9
Language
English
Region
United States
NLM ID
0370625
Subset
IM
Grants
NHLBI NIH HHS · R01HL41423-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com